Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 3/2017

01-03-2017 | Original Paper

Understanding venous malformations of the head and neck: a comprehensive insight

Authors: Giacomo Colletti, Anna Maria Ierardi

Published in: Medical Oncology | Issue 3/2017

Login to get access

Abstract

Venous malformations (VMs) are congenital vascular malformations. They are very often misnamed and thus incorrectly managed. The aim of the present paper is to provide the reader with the most updated literature available and to offer a detailed description of each single aspect of this disease. In detail, the paper discusses the epidemiology, the embryological origins and the physiopathology of VMs. Then, the clinical features of sporadic, inherited and syndromic VMs are discussed. The instrumental diagnosis is presented, and the role of US, CT, MRI and phlebography is pointed out. Differential diagnoses with other vascular malformations and tumors are described. The clinical session ends with the staging of VMs relying on MRI and rheological features. All aspects of treatment are described: conservative measures, medical treatment, sclerotherapy, laser and surgery are thoroughly discussed. A section is reserved to bony VMs. Their clinical aspects and the appropriate treatment are presented.
Literature
1.
2.
Vikkula M, Boon LM, Mulliken JB. Molecular genetics of vascular malformations. Matrix Biol. 2001;20(5):327–35.CrossRefPubMed
3.
Legiehn GM, Heran MKS. Venous malformations: classification, development, diagnosis, and interventional radiologic management. Radiol Clin N Am. 2008;46(3):545–97.CrossRefPubMed
4.
Luttun A, Carmeliet G, Carmeliet P. Vascular progenitors: from biology to treatment. Trends Cardiovasc Med. 2002;12(2):88–96.CrossRefPubMed
5.
Tille JC. Hereditary vascular anomalies: new insights into their pathogenesis. Arterioscler Thromb Vasc Biol. 2004;24(9):1578–90.CrossRefPubMed
6.
7.
Cohen MM Jr. Vascular update: morphogenesis, tumors, malformations, and molecular dimensions. Am J Med Genet. 2006;140(19):2013–38.CrossRefPubMed
8.
Gallione CJ, Pasyk KA, Boon LM, Lennon F, Johnson DW, Helmbold EA, Markel DS, Vikkula M, Mulliken JB, Warman ML. A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet. 1995;32(3):197–9.CrossRefPubMedPubMedCentral
9.
Boon LM, Mulliken JB, Enjolras O, Vikkula M. Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. Arch Dermatol. 2004;140(8):971–6.CrossRefPubMed
10.
Vikkula M, Boon LM, Mulliken JB, Olsen BR. Molecular basis of vascular anomalies. Trends Cardiovasc Med. 1998;8(7):281–92.CrossRefPubMed
11.
Belov S. Classification, terminology and nosology of congenital vascular defects. Reinbek: Einhorn-Presse; 1989. p. 25–8.
12.
Jackson IT, Carreño R, Potparic Z, Hussain K. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg. 1993;91(7):1216–30.CrossRefPubMed
13.
Enjolras O, Ciabrini D, Mazoyer E, Laurian C, Herbreteau D. Extensive pure venous malformations in the upper or lower limb: a review of 27 cases. J Am Acad Dermatol. 1997;36(2):219–25.CrossRefPubMed
14.
Dompmartin A, Acher A, Thibon P, Tourbach S, Hermans C, Deneys V, Pocock B, Lequerrec A, Labbé D, Barrellier M-T, Vanwijck R, Vikkula M, Boon LM. Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol. 2008;144(7):873–7.CrossRefPubMed
15.
Blatt J, McLean TW, Castellino SM, Burkhart CN. A review of contemporary options for medical management of hemangiomas, other vascular tumors, and vascular malformations. Pharmacol Ther. 2013;139(3):327–33.CrossRefPubMed
16.
Shirazi F, Cohen C, Fried L, Arbiser JL. Mammalian target of rapamycin (mTOR) is activated in cutaneous vascular malformations in vivo. Lymphat Res Biol. 2007;5(4):233–6.CrossRefPubMed
17.
Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatric Blood Cancer. 2011;57(6):1018–24.CrossRefPubMed
18.
Jabłońska-Trypuć A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016;31(sup1):177–83.CrossRefPubMed
19.
20.
Marler JJ. Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics. 2005;116(1):38–45.CrossRefPubMed
21.
Burrows PE, Mulliken JB, Fishman SJ, Klement GL, Folkman J. Pharmacological treatment of a diffuse arteriovenous malformation of the upper extremity in a child. J Craniofac Surg. 2009;20(1):597–602.CrossRefPubMed
22.
Colletti G, Dalmonte P, Moneghini L, Ferrari D, Allevi F. Adjuvant role of anti-angiogenic drugs in the management of head and neck arteriovenous malformations. Med Hypotheses. 2015;85(3):298–302.CrossRefPubMed
23.
Brouillard P, Boon LM, Mulliken JB, Enjolras O, Ghassibé M, Warman ML, Tan OT, Olsen BR, Vikkula M. Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (‘glomangiomas’). Am J Hum Genet. 2002;70(4):866–74.CrossRefPubMedPubMedCentral
24.
25.
Colletti G, Frigerio A, Giovanditto F, Biglioli F, Chiapasco M, Grimmer JF. Surgical treatment of vascular malformations of the facial bones. J Oral Maxillofac Surg. 2014;72(7):1326.e1–18.CrossRef
26.
Boon LM, Mulliken JB, Vikkula M, Watkins H, Seidman J, Olsen BR, Warman ML. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet. 1994;3(9):1583–7.CrossRefPubMed
27.
28.
Boon LM, Vikkula M. Multiple cutaneous and mucosal venous malformations. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993–2017.
29.
Bean WB. Blue rubber-bleb nevi of the skin and gastrointestinal tract. In: Bean WB, editor. Vascular spiders and related lesions of the skin. Springfield: Charles C. Thomas; 1958. p. 178–85.
30.
31.
Yuksekkaya H, Ozbek O, Keser M, Toy H. Blue rubber bleb nevus syndrome: successful treatment with sirolimus. Pediatrics. 2012;129(4):e1080–4.CrossRefPubMed
32.
Gorham LW, Stout AP. Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone): its relation to hemangiomatosis. J Bone Joint Surg Am. 1955;37(5):985–1004.CrossRefPubMed
33.
Jackson JB. A singular case of aborbtion of bone (a boneless arm). Boston Med Surg J. 1838;18:368–9.CrossRef
34.
Ruggieri P, Montalti M, Angelini A, Alberghini M, Mercuri M. Gorham–Stout disease: the experience of the Rizzoli Institute and review of the literature. Skelet Radiol. 2011;40(11):1391–7.CrossRef
35.
Hirayama T, Sabokbar A, Itonaga I, Watt-Smith S, Athanasou NA. Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham–Stout disease. J Pathol. 2001;195(5):624–30.CrossRefPubMed
36.
Nozaki T, Nosaka S, Miyazaki O, Makidono A, Yamamoto A, Niwa T, Tsutsumi Y, Aida N, Masaki H, Saida Y. Syndromes associated with vascular tumors and malformations: a pictorial review. Radiographics. 2013;33(1):175–95.CrossRefPubMed
37.
Maffucci A. Di un caso di encondroma ed angioma multiplo. Mov Med Chir Napoli. 1881;3:399–412.
38.
Amary MF, Damato S, Halai D, Eskandarpour M, Berisha F, Bonar F, McCarthy S, Fantin VR, Straley KS, Lobo S, Aston W, Green CL, Gale RE, Tirabosco R, Futreal A, Campbell P, Presneau N, Flanagan AM. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet. 2011;43(12):1262–5.CrossRefPubMed
39.
Pansuriya TC, van Eijk R, d’Adamo P, van Ruler MAJH, Kuijjer ML, Oosting J, Cleton-Jansen A-M, van Oosterwijk JG, Verbeke SLJ, Meijer D, van Wezel T, Nord KH, Sangiorgi L, Toker B, Liegl-Atzwanger B, San-Julian M, Sciot R, Limaye N, Kindblom L-G, Daugaard S, Godfraind C, Boon LM, Vikkula M, Kurek KC, Szuhai K, French PJ, Bovée JVMG. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet. 2011;43(12):1256–61.CrossRefPubMedPubMedCentral
40.
Cai Y, Wang R, Chen X-M, Zhao Y-F, Sun Z-J, Zhao J-H. Maffucci syndrome with the spindle cell hemangiomas in the mucosa of the lower lip: a rare case report and literature review. J Cutan Pathol. 2013;40(7):661–6.CrossRefPubMed
41.
Verdegaal SHM, Bovée JVMG, Pansuriya TC, Grimer RJ, Ozger H, Jutte PC, San-Julian M, Biau DJ, van der Geest ICM, Leithner A, Streitbürger A, Klenke FM, Gouin FG, Campanacci DA, Marec-Berard P, Hogendoorn PCW, Brand R, Taminiau AHM. Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist. 2011;16(12):1771–9.CrossRefPubMedPubMedCentral
42.
Mazoyer E, Enjolras O, Laurian C, Houdart E, Drouet L. Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach–Merritt syndrome. Clin Lab Haematol. 2002;24(4):243–51.CrossRefPubMed
43.
Lee BB, Bergan J, Gloviczki P, Laredo J, Loose DA, Mattassi R, Parsi K, Villavicencio JL, Zamboni P, International Union of Phlebology (IUP). Diagnosis and treatment of venous malformations. Consensus document of the International Union of Phlebology (IUP)-2009. Int Angiol. 2009;28(6):434–51.PubMed
44.
Lee BB, Antignani PL, Baraldini V, Baumgartner I, Berlien P, Blei F, Carrafiello GP, Grantzow R, Ianniello A, Laredo J, Loose D, Lopez Gutierrez JC, Markovic J, Mattassi R, Parsi K, Rabe E, Roztocil K, Shortell C, Vaghi M. ISVI-IUA consensus document diagnostic guidelines of vascular anomalies: vascular malformations and hemangiomas. Int Angiol. 2015;34(4):333–74.PubMed
45.
Trop I, Dubois J, Guibaud L, Grignon A, Patriquin H, McCuaig C, Garel LA. Soft-tissue venous malformations in pediatric and young adult patients: diagnosis with Doppler US. Radiology. 1999;212(3):841–5.CrossRefPubMed
46.
Paltiel HJ, Burrows PE, Kozakewich HP, Zurakowski D, Mulliken JB. Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology. 2000;214(3):747–54.CrossRefPubMed
47.
Dubois J, Soulez G, Oliva VL, Berthiaume MJ, Lapierre C, Therasse E. Soft-tissue venous malformations in adult patients: imaging and therapeutic issues. Radiographics. 2001;21(6):1531.CrossRef
48.
Dubois J, Garel L, David M, Powell J. Vascular soft-tissue tumors in infancy: distinguishing features on Doppler sonography. AJR Am J Roentgenol. 2002;178(6):1541–5.CrossRefPubMed
49.
Lee B-B, Choe YH, Ahn JM, Do YS, Kim D-I, Huh SH, Byun HS. The new role of magnetic resonance imaging in the contemporary diagnosis of venous malformation: can it replace angiography? J Am Coll Surg. 2004;198(4):549–58.CrossRefPubMed
50.
Weiss I, Lipari BA, Meyer L, Berenstein A, Waner M. Current treatment of parotid hemangiomas. Laryngoscope. 2011;121(8):1642–50.CrossRefPubMed
51.
Baker LL, Dillon WP, Hieshima GB, Dowd CF, Frieden IJ. Hemangiomas and vascular malformations of the head and neck: MR characterization. AJNR Am J Neuroradiol. 1993;14(2):307–14.PubMed
52.
53.
Eivazi B, Wiegand S, Negm H, Teymoortash A, Schulze S, Bien S, Werner JA. Orbital and periorbital vascular anomalies—an approach to diagnosis and therapeutic concepts. Acta Otolaryngol. 2010;130(8):942–51.CrossRefPubMed
54.
Gandolfo C, Krings T, Alvarez H, Ozanne A, Schaaf M, Baccin CE, Zhao W-Y, Lasjaunias P. Sinus pericranii: diagnostic and therapeutic considerations in 15 patients. Neuroradiology. 2007;49(6):505–14.CrossRefPubMed
55.
Akram H, Prezerakos G, Haliasos N, O’Donovan D, Low H. Sinus pericranii: an overview and literature review of a rare cranial venous anomaly (A review of the existing literature with case examples). Neurosurg Rev. 2011;35(1):15–26.CrossRefPubMed
56.
Jin YB, Lin XX, Chen H, Li W, Hu XJ, Ma G, Zhu L, Sun MH, Yang C, Wang W. Craniofacial venous malformations: magnetic resonance imaging features that predict treatment outcome. J Oral Maxillofac Surg. 2009;67(11):2388–96.CrossRefPubMed
57.
Goyal M, Causer PA, Armstrong D. Venous vascular malformations in pediatric patients: comparison of results of alcohol sclerotherapy with proposed MR imaging classification. Radiology. 2002;223(3):639–44.CrossRefPubMed
58.
Lee BB. Advanced management of congenital vascular malformations (CVM). Int Angiol. 2002;21(3):209–13.PubMed
59.
Lee BB. New approaches to the treatment of congenital vascular malformations (CVMs)—a single centre experience. Eur J Vasc Endovasc Surg. 2005;30(2):184–97.CrossRefPubMed
60.
Buckmiller LM, Richter GT, Suen JY. Diagnosis and management of hemangiomas and vascular malformations of the head and neck. Oral Dis. 2010;16(5):405–18.CrossRefPubMed
61.
McRae MY, Adams S, Pereira J, Parsi K, Wargon O. Venous malformations: clinical course and management of vascular birthmark clinic cases. Aust J Dermatol. 2012;54(1):22–30.CrossRef
62.
Redondo P. The hidden face of venous malformations: a multidisciplinary therapeutic approach. Arch Dermatol. 2008;144(7):922–6.CrossRefPubMed
63.
Hein KD, Mulliken JB, Kozakewich HPW, Upton J, Burrows PE. Venous malformations of skeletal muscle. Plast Reconstr Surg. 2002;110(7):1625–35.CrossRefPubMed
64.
O’Donovan JC, Donaldson JS, Morello FP, Pensler JM, Vogelzang RL, Bauer B. Symptomatic hemangiomas and venous malformations in infants, children, and young adults: treatment with percutaneous injection of sodium tetradecyl sulfate. AJR Am J Roentgenol. 1997;169(3):723–9.CrossRefPubMed
65.
Cho KJ, Williams DM, Brady TM, Weiss CA, Forrest ME, Oke EJ, Griffin DJ. Transcatheter embolization with sodium tetradecyl sulfate. Experimental and clinical results. Radiology. 1984;153(1):95–9.CrossRefPubMed
66.
Govrin-Yehudain J, Moscona AR, Calderon N, Hirshowitz B. Treatment of hemangiomas by sclerosing agents: an experimental and clinical study. Ann Plast Surg. 1987;18(6):465–9.CrossRefPubMed
67.
68.
Donnelly LF, Bisset GS, Adams DM. Marked acute tissue swelling following percutaneous sclerosis of low-flow vascular malformations: a predictor of both prolonged recovery and therapeutic effect. Pediatr Radiol. 2000;30(6):415–9.CrossRefPubMed
69.
Cabrera J, Garcia-Olmedo MA. Sclerosants in microfoam. A new approach in angiology. Int Angiol. 2001;20(4):322–9.PubMed
70.
Shin BS, Do YS, Lee B-B, Kim D-I, Chung IS, Cho HS, Kim MH, Kim GS, Kim CS, Byun HS, Shin SW, Park KB. Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure. Radiology. 2005;235(3):1072–7.CrossRefPubMed
71.
Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg. 2001;27(1):58–60.PubMed
72.
Hou R, Guo J, Hu K, Yang Y, Wang L, Kong L, Liu G, Lei D. A clinical study of ultrasound-guided intralesional injection of bleomycin A5 on venous malformation in cervical-facial region in China. J Vasc Surg. 2010;51(4):940–5.CrossRefPubMed
73.
Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg. 1999;104(1):1–11 (discussion 12–5).CrossRefPubMed
74.
Lee BB, Do YS, Byun HS, Choo IW, Kim DI, Huh SH. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results. J Vasc Surg. 2003;37(3):533–8.CrossRefPubMed
75.
Burrows PE. Endovascular treatment of slow-flow vascular malformations. Tech Vasc Interv Radiol. 2013;16(1):12–21.CrossRefPubMed
76.
Siniluoto TM, Svendsen PA, Wikholm GM, Fogdestam I, Edström S. Percutaneous sclerotherapy of venous malformations of the head and neck using sodium tetradecyl sulphate (sotradecol). Scand J Plast Reconstr Surg Hand Surg. 1997;31(2):145–50.CrossRefPubMed
77.
Barranco-Pons R, Burrows PE, Landrigan-Ossar M, Trenor CC, Alomari AI. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures. Am J Roentgenol. 2012;199(3):691–4.CrossRef
78.
Hammond B, Fairman RP, Monroe P, Glauser FL, Sugarman H, Davis D. The pulmonary hypertension of sclerosing agents is prevented by cyclooxygenase inhibitors. Am J Med Sci. 1985;290(3):98–101.CrossRefPubMed
79.
Allevi F, Rabbiosi D, Mandalà M, Colletti G. Paradoxical embolism following intralesional sclerotherapy for cervical venous malformation. BMJ Case Rep. 2014;2014. doi:10.​1136/​bcr-2014-206781.
80.
Lindsey SF, Reiders B, Mechaber HF. Life-threatening pharyngeal edema after sclerotherapy of oral venous malformations in a patient with blue rubber bleb nevus syndrome. J Dermatol Case Rep. 2013;7(3):74–6.CrossRefPubMedPubMedCentral
81.
Bekhor PS. Long-pulsed Nd:YAG laser treatment of venous lakes: report of a series of 34 cases. Dermatol Surg. 2006;32(9):1151–4.PubMed
82.
Suen JY, Waner M. Treatment of oral cavity vascular malformations using the neodymium:YAG laser. Arch Otolaryngol Head Neck Surg. 1989;115(11):1329–33.CrossRefPubMed
83.
Scherer K, Waner M. Nd:YAG lasers (1,064 nm) in the treatment of venous malformations of the face and neck: challenges and benefits. Lasers Med Sci. 2007;22(2):119–26.CrossRefPubMed
84.
85.
Frigerio A, Tan OT. Laser applications for benign oral lesions. Lasers Surg Med. 2015;47(8):643–50.CrossRefPubMed
86.
Miyazaki H, Ohshiro T, Watanabe H, Kakizaki H, Makiguchi T, Kim M, Negishi A, Yokoo S. Ultrasound-guided intralesional laser treatment of venous malformation in the oral cavity. Int J Oral Maxillofac Surg. 2013;42(2):281–7.CrossRefPubMed
87.
88.
Philipp C, Berlien HP, Waldschmidt J. Lasers in pediatric surgery: a review. J Clin Laser Med Surg. 1991;9(3):189–94.PubMed
89.
Crockett DJ, Meier JD, Wilson KF, Grimmer JF. Treatment of oral cavity venous malformations with the Nd:YAG laser using the underwater technique. Otolaryngol Head Neck Surg. 2013;149(6):954–6.CrossRefPubMed
90.
Colletti G, Colombo V, Mattassi R, Frigerio A. Strangling technique to treat large cervicofacial venous malformations: a preliminary report. Head Neck. 2014;36(10):E94–8.PubMed
91.
Wiegand S, Tiburtius J, Zimmermann AP, Güldner C, Eivazi B, Werner JA. Localization and treatment of lingual venous and arteriovenous malformations. Vasc Med. 2014;19(1):49–53.CrossRefPubMed
92.
Leung M, Leung L, Fung D, Poon W-L, Liu C, Chung K, Tang P, Tse S, Fan T-W, Chao N, Liu K. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol. Eur J Pediatr Surg. 2014;24(1):097–101.CrossRef
93.
Puig S, Aref H, Chigot V, Bonin B, Brunelle F. Classification of venous malformations in children and implications for sclerotherapy. Pediatr Radiol. 2003;33(2):99–103.CrossRefPubMed
Metadata
Title
Understanding venous malformations of the head and neck: a comprehensive insight
Authors
Giacomo Colletti
Anna Maria Ierardi
Publication date
01-03-2017
Publisher
Springer US
Published in
Medical Oncology / Issue 3/2017
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-017-0896-3

Other articles of this Issue 3/2017

Medical Oncology 3/2017 Go to the issue

Review Article

Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials

Original Paper

Irradiation enhances dendritic cell potential antitumor activity by inducing tumor cell expressing TNF-α

Original Paper

Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization

Letter to the Editor

Risk of tumor flare after nivolumab treatment in patients with irradiated field recurrence

Original Paper

Intravoxel Incoherent Motion (IVIM) Diffusion Weighted Imaging (DWI) in the Periferic Prostate Cancer Detection and Stratification

Original Paper

Does p53 codon 72 polymorphism have a prognostic value in carcinoma of the vulva and vagina?

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits